The demand of sunitinib malate is increasing, and global advancement of technology and increasing prevalence of pancreatic cancer are the prime growth drivers of the global sunitinib malate market.

The global Sunitinib Malate market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Sunitinib Malate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sunitinib Malate market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Sunitinib Malate in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Sunitinib Malate manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Topcarepharm
Njfirstpharm
J&K Scientific
Targetmol
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Purity: >99%
Purity: >98%
Purity: >97%

Segment by Application
Pancreatic Neuroendocrine Tumors
Kidney Cancer
Gastrointestinal stromal tumor